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Abstract
Background: The binding of ligands to clusters of complement-type repeat (CR)-domains in
proteins of the low-density lipoprotein receptor (LDLR) family is dependent on Ca2+ ions. One
reason for this cation requirement was identified from the crystal structure data for a CR-domain
from the prototypic LDLR, which showed the burial of a Ca2+ ion as a necessity for correct folding
and stabilization of this protein module. Additional Ca2+ binding data to other CR-domains from
both LDLR and the LDLR-related protein (LRP) have suggested the presence of a conserved Ca2+
cage within CR-domains from this family of receptors that function in endocytosis and signalling.
Results: We have previously described the binding of several ligands to a fragment comprising the
fifth and the sixth CR-domain (CR56) from LRP, as well as qualitatively described the binding of
Ca2+ ions to this CR-domain pair. In the present study we have applied the rate dialysis method to
measure the affinity for Ca2+, and show that CR56 binds 2 Ca2+ ions with an average affinity of KD
= 10.6 microM, and there is no indication of additional Ca2+ binding sites within this receptor
fragment.
Conclusions: Both CR-domains of CR56 bind a single Ca2+ ion with an affinity of 10.6 microM
within the range of affinities demonstrated for several other CR-domains.
Background
The ligand-binding domains of the entire LDLR family of
cell surface receptors are comprised of imperfect repeats of
about 40 amino acids, the CR-domains [1–3]. Each repeat
contains six cysteine residues which are disulphide linked
in the pattern one to three, two to five, and four to six, and
each repeat harbors a Ca2+ binding site [4,5]. Furthermore,
the modular domain architecture of LRP comprises sev-
eral epidermal growth factor (EGF)-precursor homology
domains, a segment spanning the plasma membrane and
a cytoplasmic domain. The entire LRP molecule might
contain as many as 39 Ca2+ binding sites, one located in
each of the 31 CR-domains [5–7], and two binding sites
present in each of 4 EGF-domain pairs [7–11] (see legend
to Figure 1A).
The understanding of how LRP binds Ca2+ ions is impor-
tant. The binding of all ligands is dependent on the pres-
ence of Ca2+ [12–14] and ligand dissociation within the
endocytic pathway has been suggested to occur as a possi-
ble consequence of the decrease in pH and the accompa-
nying loss of affinity for Ca2+ in the acidic endosomes [8].
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Ligand recognition requires key residues in the CR-
domains of the LDLR-like proteins as well as the presence
of Ca2+ ions. One important residue for this interaction is
located at the center position between the fourth and the
fifth cysteine residue, where an acidic side chain is impor-
tant for the efficient recognition of multiple protein lig-
ands [15,16]. The backbone carbonyl group of residues
located at identical positions in several domains homolo-
gous to CR5 and CR6 is involved in the coordination of a
Ca2+ ion [5,6]. The coordination sphere of the bound Ca2+
(A) Schematic representation of the domain architecture of the LRP, with domains suggested to contain a Ca2+ binding site as  shown in gray Figure 1
(A) Schematic representation of the domain architecture of the LRP, with domains suggested to contain a Ca2+ binding site as 
shown in gray. For estimation of the stoichiometric binding of Ca2+ to the entire LRP molecule, each CR-domain is a potential 
cation carrier based on the fact that all CR-domain structures described so far include a bound Ca2+ ion [5–7]. The crystal 
structure of the LDLR YWTD-repeated β-propeller does not show any cations and we assume similar lack of Ca2+ binding to 
these fragments within LRP. In contrast, some EGF-domains do bind Ca2+ and some do not. For LDLR the EGF-domain pair 
amino-terminal to the β-propeller binds 2 Ca2+ ions, and accordingly, it is assumed that the four EGF-domain pairs within LRP 
are also Ca2+ binding. The carboxy-terminal EGF-domain is not chelating a Ca2+ ion [7–11]. By these assumptions, one LRP 
molecules could bind a total of at least 39 Ca2+ ions. Rectangles ( ) represent CR-domains, pentagons ( ) represent EGF-
domains, and hexagonals ( ) for each blade of the β-propellers. (B) Ribbon representation of the canonical CR-domain folding 
and Ca2+ binding site. Left, the backbone folding of CR5LDLR (Protein Data Bank accession code 1ajj [5]) showing the location of 
the Ca2+ ion indicated as the sphere. Right, zoom of the Ca2+ cage showing the octahedral cation coordination. (C) Alignment 
of the primary structures of Ca2+-binding CR-domains with a known 3D-structure, the first, the second, the fifth, and the sixth 
CR-domain from LDLR, and the third, the seventh, and the eighth CR-domain from LRP. The symbols below the alignment 
indicate residues involved in Ca2+ chelation (‡, coordination by backbone carbonyl; †, coordination by side chain carboxyl), and 
the six conserved cysteines are indicated above the sequences with roman numbers.BMC Biochemistry 2003, 4 http://www.biomedcentral.com/1471-2091/4/7
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ion is well defined in octahedral geometry, with four car-
boxylate oxygen atoms from the acidic motif in one plan
and two carbonyl oxygen atoms completing the coordina-
tion sphere at the apices (Figure 1B).
We have previously demonstrated the specific binding of
LRP ligands to a minimum receptor fragment comprising
only 2 CR-domains [15], and focused on the ligand inter-
action with the tandem domain CR56 fragment [17,18].
The affinity for a bound Ca2+ ion has been reported for
several CR-domains, and in order to better understand the
Ca2+-dependent ligand binding properties of CR56 we
have determined the stoichiometry and affinity for Ca2+
binding to this CR-domain pair. Furthermore, we under-
took a stringent/direct method of affinity determination
using the microchamber rate dialysis method [19] inde-
pendent of the local molecular environment at the Ca2+
localization site, and could compare the determined affin-
ity with data obtained by less direct methods, e.g. fluores-
cence analysis. We conclude that in general the affinities
do not vary significantly among the CR-domains
investigated.
Results and Discussion
The demonstration of Ca2+ binding to the ubiquitin-fused
CR56 protein [15] strongly suggested that CR56 contains
at least one efficient Ca2+ binding site similar to other CR-
domains [1,5]. However, from the previously adopted
approach we could not determine the stoichiometry and
affinity between Ca2+ and CR56. This was the main objec-
tive of the current study. Furthermore, we wanted to test
whether the coupling of a CR-domain to a neighboring
domain would influence the affinity of the single CR-
domain, compared to the increasing pool of data describ-
ing the binding of Ca2+ to isolated CR-domains [6,20–23].
After affinity purification of ubiquitin-fused CR56 con-
taining the authentic amino acid sequence, we liberated
the CR56 domain pair from its fusion partner by factor Xa
cleavage (as described in ref. [15]). 2D gel analysis
showed a high degree of purity, since the recombinant
CR56 protein migrated as a single major spot (not
shown). Ca2+ binding was measured using the micro-
chamber rate dialysis technique [19,24].
The Ca2+ binding data is shown in Figure 2A, and from
Scatchard analysis of the data (Figure 2B), we conclude
that the folded CR56 domain pair binds two Ca2+ ions
with an average affinity of KD = 10.6 µM assuming two
identical binding sites. Even though there is a small deri-
vation from the exact 1:2 stoichiometry (n = 2.0 sites), the
observed n = 2.2 is within experimental error not signifi-
cantly different from 2.0. Secondly, the number is in
accord with other data determining Ca2+ affinity to tan-
dem CR-domain pair [25]. Bieri et al. found a similar sto-
ichiometry (n = 2.2) when they measured the Ca2+
binding to a concatemer of CR1LDLR-CR2LDLR, and neither
solution nor crystal structure indicate that there is more
than two Ca2+ binding sites within this fragment [7,26].
Furthermore, the recently solved crystal structure of the
LDLR luminal domain shows a single bound cation for
each CR-domain without any additional interdomain
binding sites [7]. The determined affinity is very close to
the reported Ca2+  affinities for homologous LRP CR-
domains, CR3LRP, CR7LRP, CR8LRP and for the two LDLR
CR-domains CR1LDLR and CR2LDLR (listed in Table 1),
which indicates that the binding sites might be similar.
Apparently, most CR-domains bind Ca2+ with an approx-
imate affinity KD~10–20 µM, except CR5LDLR and CR6LDLR
which show a higher affinity. Furthermore, our data sug-
gests that the various methods used to measure the affini-
ties are reliable.
The Ca2+ ions in the hitherto solved domain structures are
located in identical Ca2+ cages as for CR5LDLR described
previously by Fass and colleagues [5] (Figure 1B). From a
high level of sequence conservation for the sequences of
CR5LRP and CR6LRP compared to the sequences of the CR-
domains with a solved domain structure (Figure 1C), we
suggest that the binding site for Ca2+ within both CR5 and
CR6 are very similar to these. This is very important infor-
mation for the assignment of nuclear magnetic resonances
for the solution structure determination of CR56 (ongo-
ing project).
The demonstration of independent folding of each CR-
domain in tandem CR-domain pairs is substantiated by
the reports of a total lack of interdomain interactions, and
that Ca2+ coordination does not involve chelates from
adjacent CR-domains [27,28]. In line with this our data
suggest that two and only two Ca2+ are bound per tandem
fragment as also reported for domain pairs from LDLR
comprising CR1LDLR-CR2LDLR  and CR5LDLR-CR6LDLR
[25,27]. Since the Ca2+ affinity for CR5 and CR6 is similar
to other known binding sites, it is tempting to believe that
the Ca2+ ion is located in a similar Ca2+cage as for these
domains [1,5,6], and therefore the chelating residues
located at identical positions within the primary structure
is also cation coordinating in these domains. If this
indeed is the case, we have recently demonstrated that the
two residues speculated to provide electrons for Ca2+coor-
dination via their backbone functional group (Trp-953/
Asp-958 in CR5 and Trp-994/Asp-999 in CR6) both con-
tribute significantly to ligand binding [17,18]. The possi-
bility that Ca2+ most likely are intimately linked to these
residues suggest that Ca2+ binding exerts influence on lig-
and binding to CR-domains, because of a lack of dynamic
and flexibility of residues at this particular position. In
addition, especially the acidic residues is also involved in
the intramolecular binding of CR-domains to the EGF-
precursor homology domain at low pH, speculated toBMC Biochemistry 2003, 4 http://www.biomedcentral.com/1471-2091/4/7
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(A) The Ca2+-affinity of CR56 was determined by rate dialysis [Ca2+]bound/[CR56] versus the free Ca2+ concentration Figure 2
(A) The Ca2+-affinity of CR56 was determined by rate dialysis [Ca2+]bound/[CR56] versus the free Ca2+ concentration. The con-
centration of CR56 was 15 µM throughout the analysis. (B) Scatchard analysis of the data shown in panel A. The solid line rep-
resents the best fit by least-squares analysis as described in the materials and methods section. The fact that the experimental 
points are located on a straight line indicates absence of cooperativity between the two Ca2+ binding sites. Strong positive 
cooperativity would result in upward curvature, while strong negative cooperativity would result in downward curvature of 
the Scatchard plot. The average affinity is determined to, KD = 10.6 µM assuming two identical sites (n = 2.2).BMC Biochemistry 2003, 4 http://www.biomedcentral.com/1471-2091/4/7
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result in structural rearrangement and ligand release
within endosomes, underscoring the importance of
understanding the local environment around the Ca2+
binding site [7].
Conclusions
Both CR-domains of the CR56-domain pair bind a single
Ca2+ ion with an average affinity, KD~10.6 µM.
Methods
Proteins
Production and RAP-affinity purification of the ubiquitin-
fused CR-domain pair comprising the fifth and the sixth
CR-domain from LRP (see Figure 1) was described previ-
ously [15]. Purity was verified by two-dimensional gel
electrophoresis showing the sample to be highly homoge-
neous (not shown).
Calcium binding analysis
Qualitative  45Ca blotting analysis to ubiquitin-fused
CR56 has been described [15]. The quantitative rate dial-
ysis method [19] was applied to determine the Ca2+ bind-
ing constants for CR56. The binding experiments were
performed in a medium containing 10 mM HEPES pH.
7.0, 150 mM NaCl and a final CR56 concentration at 15
µM. Buffers and protein solutions were passed through a
Chelex 100 column (BioRAD) in order to obtain cation
free solutions before use. The resin was pre-equilibrated
with HEPES binding buffer before use. We have previ-
ously shown that this procedure is able to bring the Ca2+
content of the solutions to negligible levels as determined
by atomic absorption spectrometry [29]. The dialysis
membrane was of cellulose, Type 14.10, molecular cut-off
5000, from Diachema (Munich, Germany). The following
equation was used to calculate the free Ca2+ concentration
from the total Ca2+ concentration:
[Ca2+]free = - [Ca2+]total [k*(t+t0)]-1 ln [(Aleft - Aright)/(Aleft +
Aright)]
where k is a pre-determined rate constant, t is time of dial-
ysis and t0 is an experimentally determined value which is
dependent upon the procedure of filling, withdrawal, and
rinsing of chambers and varies with the substance dia-
lysed [19]. Aleft and Aright denote the radioactivity in the
left and right solution, respectively, after dialysis meas-
ured by liquid scintillation counting in an LKB Wallac
1218 Rackbeta scintillation counter. The values of k and t0
for the Ca2+ ligand used were 0.04650 min-1 and 0.18 min.
They were determined in separate experiments with no
protein present and using varying dialysis times as
described in detail [19]. In short, values of ln [(Aleft -
Aright)/(Aleft + Aright)] are plotted versus the dialysis time.
The rate constant k is then determined from the slope of
the curve while t0 is determined as the numerical value of
the intercept with the time-axis (x-axis). The average
number of Ca2+ ions bound per protein molecule, r, was
calculated from
r = ([Ca2+]total - [Ca2+]free)/ [CR56]
Under the presumption that CR56 contains a number, n,
of identical and independent Ca2+-binding sites the bind-
Table 1: Ca2+ binding properties of various CR-domains
CR-domain Ca2+ affinity (KD) µM References Method a) Conditions
CR1LDLR 7 [22] Fluorescence 25°C
10 [30]
CR2LDLR 14 [25]
CR5LDLR 0.040 [27] Fluorescence pH 7.0
0.070 [20,27] Fluorescence pH 7.0
0.500 [6] ITC pH 7.4, 30°C
13 [6] ITC pH 5.0, 30°C
CR6LDLR 0.200 [27] Fluorescence pH 7.0
CR3LRP 8 [6] ITC pH 7.4, 30°C
24 [22] Fluorescence 25°C
CR5LRP 11 The present data Rate dialysis pH 7.4, 37°C
CR6LRP 11 The present data Rate dialysis pH 7.4, 37°C
CR7LRP 13 [6] ITC pH 7.4, 30°C
CR8LRP 6 [6] ITC pH 7.4, 30°C
13 [22] Fluorescence 25°C
CRTva 40 [23] ITC pH 7.4, 30°C
a) ITC; Isothermal titration calorimetry CRXLDLR, CRXLRP, and CRTva denote the Xth CR-domain counting from the amino-terminal end of LDLR, 
LRP and the Tva receptor of avian leucosis and sarcoma virus type A, respectively.BMC Biochemistry 2003, 4 http://www.biomedcentral.com/1471-2091/4/7
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ing isotherm was fitted to the Scatchard equation by linear
regression:
r/ [Ca2+]free = - r/KD + n/KD,
where KD is the dissociation constant.
Abbreviations
CR-domain, complement-type repeat domain; EGF, epi-
dermal growth factor; LDLR, low-density lipoprotein
receptor; LRP, LDLR-related protein
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